Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Medchemexpress LLC SNX-0723 | 1073969-18-2 | 99.1% | 399.46 g·mol^-1 | C22H26FN3O3 | 50 MG
SDP

Catalog No. 5000227344
Encompass_Preferred

SNX-0723 is a brain-permeable small-molecule Hsp90 inhibitor reported to have anti-Plasmodium and antitumor activity. It is supplied for research use in high-purity solid and solution formats for in vitro and in vivo studies.

  • Potent Hsp90 inhibitor with reported biological activity.
  • Reported purity ~99.1% suitable for research applications.
  • Molecular weight 399.46 g·mol⁻¹ and formula C22H26FN3O3.
  • Available as solid powder and as DMSO solution for flexibility.
  • Stored under recommended low-temperature conditions for stability.

Catalog No. 50-002-27344 Supplier Medchemexpress LLC Supplier No. HY11904650MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

SNX-0723 is a brain-permeable small-molecule Hsp90 inhibitor reported to have anti-Plasmodium and antitumor activity. It is supplied for research use in high-purity solid and solution formats for in vitro and in vivo studies.

  • Potent Hsp90 inhibitor with reported biological activity.
  • Reported purity ~99.1% suitable for research applications.
  • Molecular weight 399.46 g·mol⁻¹ and formula C22H26FN3O3.
  • Available as solid powder and as DMSO solution for flexibility.
  • Stored under recommended low-temperature conditions for stability.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.